Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel alpha-subunits

Citation
T. Weiser et al., Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel alpha-subunits, MOLEC PHARM, 56(6), 1999, pp. 1238-1244
Citations number
36
Categorie Soggetti
Pharmacology & Toxicology
Journal title
MOLECULAR PHARMACOLOGY
ISSN journal
0026895X → ACNP
Volume
56
Issue
6
Year of publication
1999
Pages
1238 - 1244
Database
ISI
SICI code
0026-895X(199912)56:6<1238:DIORWT>2.0.ZU;2-N
Abstract
Mexiletine is a class I antiarrhythmic drug with neuroprotective effects in models of brain ischemia attributable to inhibition of brain sodium channe ls. We compared effects of R-mexiletine on wild-type and mutant rat brain ( rbIIA) and heart (rh1) sodium channel alpha-subunits transiently expressed in tsA-201 cells. R-mexiletine induced tonic and frequency-dependent block and bound with a 26-fold (brain) or 35-fold (heart) higher affinity to inac tivated sodium channels. Affinities of both resting and inactivated channel s for R-mexiletine block were approximately 2-fold higher for heart than fo r brain channels. Mutations in transmembrane segment IVS6 of heart (rhF1762 A) and brain (rbF1764A and rbY1771A) channels, which reduce block by other local anesthetics, reduced high-affinity block of inactivated channels and frequency-dependent block of open channels by R-mexiletine and abolished th e difference in affinity between brain and heart sodium channels. Unlike pr evious local anesthetics studied, the strongest effect was observed for mut ation rbY1771A. Comparison of mutations of the homologous phenylalanine res idue in brain and heart channels showed striking differences in the effects of the mutations. rbF1764A reduced drug block by slowing R-mexiletine bind ing to inactivated channels, whereas rhF1762A reduced block by increasing t he rate of dissociation from inactivated and resting channels. Thus, rbF176 4/rhF1762 is a critical determinant of affinity and tissue-specific differe nces in mexiletine block of brain and heart sodium channels, but its role i n drug interaction differs in these two channel isoforms.